Showing results (91-100 of 253) with videos related to

Sort By:
Pageof 26
Recenti Progressi in Medicina|June 16, 2026
[Lean and Value-Based Healthcare methods to support the chronic heart failure care model.]Leonardo Gianluca Lacerenza, Paolo Corradini, Bruno Sposato, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 4, 2014
Impact of cytomegalovirus replication and cytomegalovirus serostatus on the outcome of patients with B cell lymphoma after allogeneic stem cell transplantationJacopo Mariotti, Francesco Maura, Francesco Spina, et al.
Bone Marrow Transplantation|October 9, 2024
Role of bridging RT in relapsed/refractory diffuse large B-cell lymphoma undergoing CAR-T therapy: a multicenter studyStefania Bramanti, Daniele Mannina, Annalisa Chiappella, et al.
Haematologica|June 14, 2006
Bortezomib with or without dexamethasone in relapsed multiple myeloma following allogeneic hematopoietic cell transplantationBenedetto Bruno, Francesca Patriarca, Roberto Sorasio, et al.
Hematological Oncology|April 30, 2022
Targeting CD19 in diffuse large B-cell lymphoma: An expert opinion paperSarah Bailly, Guillaume Cartron, Sridhar Chaganti, et al.
Cancer Research|April 6, 2007
IFN-gamma enhances the antimyeloma activity of the fully human anti-human leukocyte antigen-DR monoclonal antibody 1D09C3Carmelo Carlo-Stella, Anna Guidetti, Massimo Di Nicola, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 7, 2010
High-dose therapy and autologous stem-cell transplantation in Waldenstrom macroglobulinemia: the Lymphoma Working Party of the European Group for Blood and Marrow TransplantationCharalampia Kyriakou, Carmen Canals, David Sibon, et al.
Leukemia & Lymphoma|May 4, 2011
Lenalidomide can induce long-term responses in patients with multiple myeloma relapsing after multiple chemotherapy lines, in particular after allogeneic transplantFrancesco Spina, Vittorio Montefusco, Claudia Crippa, et al.
Haematologica|May 7, 2013
Brentuximab vedotin in relapsed/refractory Hodgkin's lymphoma: the Italian experience and results of its use in daily clinical practice outside clinical trialsPier Luigi Zinzani, Simonetta Viviani, Antonella Anastasia, et al.
Blood|March 29, 2003
Long-term remission in mantle cell lymphoma following high-dose sequential chemotherapy and in vivo rituximab-purged stem cell autografting (R-HDS regimen)Alessandro M Gianni, Michele Magni, Maurizio Martelli, et al.
Pageof 26